To delineate the role of IL-18 and IL-1 in inflammasome-mediated signaling in early NAFLD, we blocked these signaling pathways using Il-18r −/− and Il-1r −/− mice. This evidence concerns the gene IL18R1 and metabolic dysfunction-associated steatotic liver disease.